Could these eye drops stop Kids' nearsightedness from getting worse?

NCT ID NCT07522242

Recruiting now Disease control Sponsor: Laboratoires Thea Source: ClinicalTrials.gov ↗

First seen Apr 15, 2026 · Last updated Apr 29, 2026 · Updated 4 times

Summary

This study tests whether T10430 eye drops can safely slow the progression of nearsightedness (myopia) in children aged 6 to 12. Myopia often starts in childhood and can lead to serious eye problems later in life. The trial will measure side effects and how well the drops control eye growth over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Abdali Hospital
NOT_YET_RECRUITING

Amman, Jordan
Hôpital Charles Nicolle
NOT_YET_RECRUITING

Tunis, Tunisia
Hôpital Farhat-Hached
NOT_YET_RECRUITING

Sousse, Tunisia
Hôpital Universitaire Tahar Sfar Mahdia
NOT_YET_RECRUITING

Mahdia, Tunisia
IATROS INTERNATIONAL PTY Ltd
RECRUITING

Brandwag, South Africa
Irbid Specialty Hospital
NOT_YET_RECRUITING

Irbid, Jordan
Istiklal Hospital
NOT_YET_RECRUITING

Amman, Jordan
Jordan University Hospital
NOT_YET_RECRUITING

Amman, Jordan
Pharmaceutical research center at Jordan University of Science and Technology
NOT_YET_RECRUITING

Irbid, Jordan
Pretoria Eye Institute Research Foundation
RECRUITING

Pretoria, South Africa

Conditions

Explore the condition pages connected to this study.

MYOPIA